MDL is fully accredited by the College of American Pathologist (CAP). It is operated by certified personnel and qualified doctors with expertise in molecular pathology who ensure the accuracy of test results and the effectiveness of the lab.
MDL commits to quality service by strictly adhere to clinical laboratory regulation.
- MDL provides fast and accurate results for existing diagnostic tests.
- MDL implements and develops high-complexity tests to meet clinical needs.
- MDL collaborates with clinical research.
MDL performs nucleic acid-based test of human sample to provide reliable test results to clinicians.
- Aptima Combo2 CT/GC Assay – FDA-approved target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA from Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC). CT and GC infections are two of the most common sexually transmitted infections worldwide. This test aids in the diagnosis of chlamydial and/or gonococcal urogenital disease. This test can be done on a wide variety of patients’ samples including endocervical, vaginal, male urethral swab specimens, PreservCyt liquid Pap specimens, and in female and male urine samples from symptomatic and asymptomatic individuals.
For more information please contact:
Medical Technologist III
Molecular Diagnostics Laboratory